Alison joins the firm from Fieldfisher where she has led the life sciences group and sat on their Executive Committee for a number of years.
Highly regarded for her life sciences regulatory and transactional work, Alison acts for medical device, pharmaceutical and biotech companies, helping them to expand in Europe and other jurisdictions around the world.